Journal
WORLD JOURNAL OF CLINICAL ONCOLOGY
Volume 5, Issue 4, Pages 633-645Publisher
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.5306/wjco.v5.i4.633
Keywords
Carcinoma; Non-small-cell lung; Chemotherapy; Adjuvant; Radiotherapy; Biological therapy; Biomarker
Categories
Ask authors/readers for more resources
Non-small-cell lung cancer remains a leading cause of death around the world. For most cases, the only chance of cure comes from resection for localised disease, however relapse rates remain high following surgery. Data has emerged over recent years regarding the utility of adjuvant chemotherapy for improving disease-free and overall survival of patients following curative resection. This paper reviews the clinical trials that have been conducted in this area along with the studies integrating radiation therapy in the adjuvant setting. The role of prognostic gene signatures are reviewed as well as ongoing clinical trials including those incorporating biological or targeted therapies. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available